Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and framework
A rich pipeline of therapeutic candidates is advancing for Parkinson’s disease, many of which are targeting the underlying pathophysiology of disease. Emerging evidence grounded in novel genetics and biomarker discoveries is illuminating the true promise of precision medicine-based therapeutic strat...
Main Authors: | Christopher Denaro, Diane Stephenson, Martijn L. T. M. Müller, Benedetto Piccoli, Karim Azer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Systems Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsysb.2024.1351555/full |
Similar Items
-
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy
by: Jin Wang, et al.
Published: (2021-06-01) -
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
by: Giulia Straccia, et al.
Published: (2022-09-01) -
Concept and application of the probability of pharmacological success (PoPS) as a decision tool in drug development: a position paper
by: Chao Chen, et al.
Published: (2023-01-01) -
A Review of Quantitative Systems Pharmacology Models of the Coagulation Cascade: Opportunities for Improved Usability
by: Douglas Chung, et al.
Published: (2023-03-01) -
Quantitative clinical pharmacology and patient-centered healthcare technologies: perspectives 2030
by: V. I. Petrov, et al.
Published: (2022-07-01)